![2-(4-Methylphenyl)-5,6,7,8-tetrahydroimidazo[2,1-b][1,3]benzothiazole hydrobromide](https://static.cymitquimica.com/products/3D/img/FM43025.png "Clique para ampliar")
2-(4-Methylphenyl)-5,6,7,8-tetrahydroimidazo[2,1-b][1,3]benzothiazole hydrobromide
CAS: 511296-88-1
Ref. 3D-FM43025
| 1g | A consultar | ||
| 2g | A consultar | ||
| 5g | A consultar | ||
| 10g | A consultar | ||
| 500mg | A consultar |
Informação sobre produto
2-(4-Methylphenyl)-5,6,7,8-tetrahydroimidazo[2,1-b][1,3]benzothiazole hydrobromide is a novel agent that has been shown to be effective in the treatment of non-small cell lung cancer. The mechanism of action involves inhibition of sirtuin (SIRT) enzymes and consequent induction of apoptosis in cancer cells. The drug also inhibits the production of mononucleotides that are essential for DNA synthesis and RNA transcription. 2-(4-Methylphenyl)-5,6,7,8-tetrahydroimidazo[2,1-b][1,3]benzothiazole hydrobromide has been tested in clinical trials for the treatment of depression. This drug has also been shown to have muscle strengthening effects by increasing levels of creatine kinase and insulin like growth factor 1 (IGF-
Propriedades químicas
Consulta técnica sobre: 3D-FM43025 2-(4-Methylphenyl)-5,6,7,8-tetrahydroimidazo[2,1-b][1,3]benzothiazole hydrobromide
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.
